Skip to main content
. 2023 May 31;15(2):72–78. doi: 10.4103/jgid.jgid_134_22

Table 4.

Factors associated with mortality in melioidosis patients (n=70)

Variables Nonsurvivors (35%), n (%) Survivors (35%), n (%) Unadjusted Adjusted


HR (95% CI) P HR (95% CI) P
Age
 ≥50 (32) 16 (50.0) 16 (50.0) 0.92 (0.47–1.78) 0.80 - -
 <50 (38) 19 (50.0) 19 (50.0) 1
Sex
 Male (63) 31 (49.2) 32 (50.8) 0.87 (0.31–2.45) 0.79 - -
 Female (7) 4 (57.1) 3 (42.9) 1
Diabetes
 Yes (55) 28 (50.9) 27 (49.1) 1.24 (0.54–2.84) 0.61 - -
 No (15) 7 (46.7) 8 (53.3) 1
CKD
 Yes (9) 8 (88.9) 1 (11.1) 2.14 (0.97–4.73) 0.06 - -
 No (61) 27 (44.3) 34 (55.7) 1
Alcoholism
 Yes (43) 23 (53.5) 20 (46.5) 1.27 (0.63–2.56) 0.50 - -
 No (27) 12 (44.4) 15 (55.6) 1
Occupational exposure
 Yes (55) 30 (54.5) 25 (45.5) 1.96 (0.76–5.06) 0.16 - -
 No (15) 5 (33.3) 10 (66.7) 1
Risk factors
 Present 32 (49.2) 33 (50.8) 0.81 (0.25–2.64) 0.72 - -
 Absent 3 (60.0) 2 (40.0) 1
Bacteremia
 Yes (47) 32 (68.1) 15 (31.9) 7.89 (2.41–25.87) 0.001 3.62 (0.96–13.72) 0.06
 No (23) 3 (13.0) 20 (87.0) 1
Sepsis
 Yes (33) 27 (81.8) 6 (18.2) 6.19 (2.79–13.73) <0.001 3.50 (1.44–8.54) 0.01
 No (37) 8 (21.6) 29 (78.4) 1
Presentation
 Acute (65) 31 (47.7) 34 (52.3) 0.60 (0.21–1.69) 0.33 - -
 Chronic(5) 4 (80.0) 1 (20.0) 1

Presence of any one risk factor. HR: Hazard ratio, CI: Confidence interval, CKD: Chronic kidney disease